Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.955 USD | -3.69% | -6.67% | -90.43% |
Business Summary
Number of employees: 41
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 17-01-31 | |
Eric Easom
FOU | Founder | 56 | 17-01-31 |
Lucy Day
DFI | Director of Finance/CFO | 65 | 19-10-31 |
Paul Eckburg
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-10-31 |
Jennifer Huber
LAW | General Counsel | - | - |
Josh Eizen
LAW | General Counsel | 46 | 22-08-31 |
Corporate Officer/Principal | - | 19-10-31 | |
Kevin Krause
PRN | Corporate Officer/Principal | 49 | 21-07-31 |
Sanjay Chanda
PRN | Corporate Officer/Principal | 59 | 19-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 60 | 17-01-31 | |
Patricia Martin
BRD | Director/Board Member | 63 | 21-03-31 |
Melvin Spigelman
BRD | Director/Board Member | 75 | 22-01-31 |
Director/Board Member | 58 | 22-05-08 | |
Robin Readnour
BRD | Director/Board Member | 60 | 19-10-31 |
Stephanie Wong
BRD | Director/Board Member | 50 | 21-03-31 |
Kabeer Aziz
BRD | Director/Board Member | 34 | 19-10-31 |
Eric Easom
FOU | Founder | 56 | 17-01-31 |
Gilbert Marks
BRD | Director/Board Member | 66 | 20-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,829,040 | 22,321,237 ( 74.83 %) | 0 | 74.83 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-90.09% | 60.55M | |
+51.85% | 57.87B | |
+40.63% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ANTX Stock
- Company AN2 Therapeutics, Inc.